Who is sponsoring NCT03175913?

NCT03175913 is sponsored by The Catholic University of Korea.

What condition does NCT03175913 study?

NCT03175913 studies Low Back Pain.

What drugs are being tested in NCT03175913?

Interventions: vapocoolant spray, local infiltration.

What is the status of NCT03175913?

NCT03175913 is currently COMPLETED.

Last reviewed 2017-06-14 · How we verify

Vapocoolant Spray for Reducing the Pain of Spinal Needle Insertion

NCT03175913 NA COMPLETED

This was a single-blind, randomized controlled trial. Sixty-six patients who underwent caudal epidural injection were randomized into the vapocoolant spray group or local infiltration group. Before the insertion of a 20-gauge spinal needle, the subcutaneous tissue was infiltrated with 3 ml of 2% lidocaine in the local infiltration group and vapocoolant spray was applied just before the spinal needle insertion in the spray group. 100-mm visual analog scale to evaluate the pain intensity of spinal needle insertion and a five-point Likert scale for patient satisfaction and preference for repeated use were compared between the two groups.

Details

Lead sponsor	The Catholic University of Korea
Phase	NA
Status	COMPLETED
Enrolment	66
Start date	Sun Jun 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Low Back Pain

Interventions

vapocoolant spray
local infiltration